Lysosomes as mediators of drug resistance in cancer

Drug Resistance Updates

Volumn 24, Issue , 2016, Pages 23-33

  Zhitomirsky, Benny ^a   Assaraf, Yehuda G ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

cancer; Chemotherapeutics; Drug sequestration; Drug transport; Lysosomes; Multidrug resistance

Indexed keywords

ANTHRACYCLINE; BAFILOMYCIN A1; BREAST CANCER RESISTANCE PROTEIN; CAMPTOTHECIN; CARBOPLATIN; CHLOROQUINE; CISPLATIN; COPPER; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE; DAUNORUBICIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ELLIPTICINE; ERLOTINIB; GEFITINIB; IMATINIB; LAPATINIB; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOME ENZYME; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOXANTRONE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; OXALIPLATIN; PAZOPANIB; PROTEIN 14 3 3; SUNITINIB; VINCRISTINE; ANTINEOPLASTIC AGENT;

ALKALINIZATION; ARTICLE; BREAST CARCINOMA; CANCER RESISTANCE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CYTOTOXICITY; DRUG CLEARANCE; DRUG DISTRIBUTION; ENDOCYTOSIS; ENZYME INHIBITION; EXOCYTOSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LYSOSOME; LYSOSOME MEMBRANE; NON SMALL CELL LUNG CANCER; OVARY CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; WILSON DISEASE; DRUG EFFECTS; DRUG RESISTANCE; METABOLISM; NEOPLASMS; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, NEOPLASM; HUMANS; LYSOSOMES; NEOPLASMS;

EID: 84950157673     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2015.11.004     Document Type: Article

References (95)

1. J. Abraham, N.N. Salama, and A.K. Azab The role of P-glycoprotein in drug resistance in multiple myeloma Leuk. Lymphoma 56 2015 26 33
2. Y. Adar, M. Stark, E.E. Bram, P. Nowak-Sliwinska, H. van den Bergh, G. Szewczyk, T. Sarna, A. Skladanowski, A.W. Griffioen, and Y.G. Assaraf Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers Cell Death Dis. 3 2012 pe293
3. S. Aits, and M. Jaattela Lysosomal cell death at a glance J. Cell Sci. 126 2013 1905 1912
4. A. Ala, A.P. Walker, K. Ashkan, J.S. Dooley, and M.L. Schilsky Wilson's disease Lancet 369 2007 397 408
5. N. Altan, Y. Chen, M. Schindler, and S.M. Simon Defective acidification in human breast tumor cells and implications for chemotherapy J. Exp. Med. 187 1998 1583 1598
6. N.W. Andrews Regulated secretion of conventional lysosomes Trends Cell Biol. 10 2000 316 321
7. H. Appelqvist, P. Waster, K. Kagedal, and K. Ollinger The lysosome: from waste bag to potential therapeutic target J. Mol. Cell. Biol. 5 2013 214 226
8. E.L. Aronovich, and P.B. Hackett Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier Mol. Genet. Metab. 114 2015 83 93
9. Y.G. Assaraf Molecular basis of antifolate resistance Cancer Metastasis Rev. 26 2007 153 181
10. Y.G. Assaraf The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis Drug Resist. Updat. 9 2006 227 246
11. J. Bertinato, E. Swist, L.J. Plouffe, S.P. Brooks, and R.M. L'Abbe Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells Biochem. J. 409 2008 731 740
12. B.G. Blair, C.A. Larson, P.L. Adams, P.B. Abada, C.E. Pesce, R. Safaei, and S.B. Howell Copper transporter 2 regulates endocytosis and controls tumor growth and sensitivity to cisplatin in vivo Mol. Pharmacol. 79 2011 157 166
13. B.G. Blair, C.A. Larson, R. Safaei, and S.B. Howell Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin Clin. Cancer Res. 15 2009 4312 4321
14. R. Callaghan, F. Luk, and M. Bebawy Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab. Dispos. 42 2014 623 631
15. B. Chapuy, R. Koch, U. Radunski, S. Corsham, N. Cheong, N. Inagaki, N. Ban, D. Wenzel, D. Reinhardt, A. Zapf, S. Schweyer, F. Kosari, W. Klapper, L. Truemper, and G.G. Wulf Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration Leukemia 22 2008 1576 1586
16. B. Chapuy, M. Panse, U. Radunski, R. Koch, D. Wenzel, N. Inagaki, D. Haase, L. Truemper, and G.G. Wulf ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug Haematologica 94 2009 1528 1536
17. S.S. Chauhan, X.J. Liang, A.W. Su, A. Pai-Panandiker, D.W. Shen, J.A. Hanover, and M.M. Gottesman Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines Br. J. Cancer 88 2003 1327 1334
18. H.H. Chen, J.J. Yan, W.C. Chen, M.T. Kuo, Y.H. Lai, W.W. Lai, H.S. Liu, and W.C. Su Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy Lung Cancer 75 2012 228 234
19. S. Dasari, and P.B. Tchounwou Cisplatin in cancer therapy: molecular mechanisms of action Eur. J. Pharmacol. 740 2014 364 378
20. C. de Duve, T. de Barsy, B. Poole, A. Trouet, P. Tulkens, and F. Van Hoof Commentary. Lysosomotropic agents Biochem. Pharmacol. 23 1974 2495 2531
21. M. Duvvuri, S. Konkar, R.S. Funk, J.M. Krise, and J.P. Krise A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells Biochemistry 44 2005 15743 15749
22. M. Duvvuri, and J.P. Krise Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review Front. Biosci. 10 2005 1499 1509
23. Y. Feng, D. He, Z. Yao, and D.J. Klionsky The machinery of macroautophagy Cell Res. 24 2014 24 41
24. P. Ferrao, P. Sincock, S. Cole, and L. Ashman Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia Leuk. Res. 25 2001 395 405
25. J.P. Gillet, and M.M. Gottesman Advances in the molecular detection of ABC transporters involved in multidrug resistance in cancer Curr. Pharm. Biotechnol. 12 2011 686 692
26. S.D. Goldman, R.S. Funk, R.A. Rajewski, and J.P. Krise Mechanisms of amine accumulation in, and egress from, lysosomes Bioanalysis 1 2009 1445 1459
27. N. Gonen, and Y.G. Assaraf Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance Drug Resist. Updat. 15 2012 183 210
28. Y. Gong, M. Duvvuri, M.B. Duncan, J. Liu, and J.P. Krise Niemann-Pick C1 protein facilitates the efflux of the anticancer drug daunorubicin from cells according to a novel vesicle-mediated pathway J. Pharmacol. Exp. Ther. 316 2006 242 247
29. Y. Gong, M. Duvvuri, and J.P. Krise Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60 J. Biol. Chem. 278 2003 50234 50239
30. K.J. Gotink, H.J. Broxterman, M. Labots, R.R. de Haas, H. Dekker, R.J. Honeywell, M.A. Rudek, L.V. Beerepoot, R.J. Musters, G. Jansen, A.W. Griffioen, Y.G. Assaraf, R. Pili, G.J. Peters, and H.M. Verheul Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance Clin. Cancer Res. 17 2011 7337 7346
31. K.J. Gotink, H.J. Broxterman, M. Labots, R.R. de Haas, H. Dekker, R.J. Honeywell, M.A. Rudek, L.V. Beerepoot, R.J. Musters, G. Jansen, A.W. Griffioen, Y.G. Assaraf, R. Pili, G.J. Peters, and H.M. Verheul Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance Clin. Cancer Res. 17 2012 7337 7346
32. K.J. Gotink, M. Rovithi, R.R. de Haas, R.J. Honeywell, H. Dekker, D. Poel, K. Azijli, G.J. Peters, H.J. Broxterman, and H.M. Verheul Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib sorafenib and pazopanib Cell. Oncol. (Dordr.) 38 2015 119 129
33. M.M. Gottesman Mechanisms of cancer drug resistance Annu. Rev. Med. 53 2002 615 627
34. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2 2002 48 58
35. M.M. Gottesman, and V. Ling The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research FEBS Lett. 580 2006 998 1009
36. M.M. Gottesman, I. Pastan, and S.V. Ambudkar P-glycoprotein and multidrug resistance Curr. Opin. Genet. Dev. 6 1996 610 617
37. L. Groth-Pedersen, and M. Jaattela Combating apoptosis and multidrug resistant cancers by targeting lysosomes Cancer Lett. 332 2013 265 274
38. L. Groth-Pedersen, M.S. Ostenfeld, M. Hoyer-Hansen, J. Nylandsted, and M. Jaattela Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine Cancer Res. 67 2007 2217 2225
39. M.T. Gyparaki, and A.G. Papavassiliou Lysosome: the cell's 'suicidal bag' as a promising cancer target Trends Mol. Med. 20 2014 239 241
40. S. Harrach, and G. Ciarimboli Role of transporters in the distribution of platinum-based drugs Front. Pharmacol. 6 2015 85
41. M. Herlevsen, G. Oxford, C.R. Owens, M. Conaway, and D. Theodorescu Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes Mol. Cancer Ther. 6 2007 1804 1813
42. C. Holohan, S. Van Schaeybroeck, D.B. Longley, and P.G. Johnston Cancer drug resistance: an evolving paradigm Nat. Rev. Cancer 13 2013 714 726
43. A.K. Holzer, G. Samimi, K. Katano, W. Naerdemann, X. Lin, R. Safaei, and S.B. Howell The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells Mol. Pharmacol. 66 2004 817 823
44. J. Hrabeta, T. Groh, M.A. Khalil, J. Poljakova, V. Adam, R. Kizek, J. Uhlik, H. Doktorova, T. Cerna, E. Frei, M. Stiborova, and T. Eckschlager Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells Int. J. Oncol. 47 2015 971 980
45. C.P. Huang, M. Fofana, J. Chan, C.J. Chang, and S.B. Howell Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin Metallomics 6 2014 654 661
46. S.J. Hurwitz, M. Terashima, N. Mizunuma, and C.A. Slapak Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes Blood 89 1997 3745 3754
47. S. Ishida, J. Lee, D.J. Thiele, and I. Herskowitz Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals Proc. Natl. Acad. Sci. U.S.A. 99 2002 14298 14302
48. G. Jansen, H. Barr, I. Kathmann, M.A. Bunni, D.G. Priest, P. Noordhuis, G.J. Peters, and Y.G. Assaraf Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration Mol. Pharmacol. 55 1999 761 769
49. G.V. Kalayda, C.H. Wagner, I. Buss, J. Reedijk, and U. Jaehde Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells BMC Cancer 8 2008 p175
50. T. Kallunki, O.D. Olsen, and M. Jaattela Cancer-associated lysosomal changes: friends or foes? Oncogene 32 2013 1995 2004
51. A.M. Kaufmann, and J.P. Krise Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications J. Pharm. Sci. 96 2007 729 746
52. F. Kazmi, T. Hensley, C. Pope, R.S. Funk, G.J. Loewen, D.B. Buckley, and A. Parkinson Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells) Drug Metab. Dispos. 41 2013 897 905
53. E.S. Kim, X. Tang, D.R. Peterson, D. Kilari, C.W. Chow, J. Fujimoto, N. Kalhor, S.G. Swisher, D.J. Stewart, I.I. Wistuba, and Z.H. Siddik Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer Lung Cancer 85 2014 88 93
54. M. Komatsu, T. Sumizawa, M. Mutoh, Z.S. Chen, K. Terada, T. Furukawa, X.L. Yang, H. Gao, N. Miura, T. Sugiyama, and S. Akiyama Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance Cancer Res 60 2000 1312 1316
55. S. Kunjachan, B. Rychlik, G. Storm, F. Kiessling, and T. Lammers Multidrug resistance: physiological principles and nanomedical solutions Adv. Drug Deliv. Rev. 65 2013 1852 1865
56. A.K. Larsen, A.E. Escargueil, and A. Skladanowski Resistance mechanisms associated with altered intracellular distribution of anticancer agents Pharmacol. Ther. 85 2000 217 229
57. Y.Y. Lee, C.H. Choi, I.G. Do, S.Y. Song, W. Lee, H.S. Park, T.J. Song, M.K. Kim, T.J. Kim, J.W. Lee, D.S. Bae, and B.G. Kim Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy Gynecol. Oncol. 122 2011 361 365
58. X. Lin, T. Okuda, A. Holzer, and S.B. Howell The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae Mol. Pharmacol. 62 2002 1154 1159
59. B. Liu, H. Du, R. Rutkowski, A. Gartner, and X. Wang LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis Science 337 2012 351 354
60. Y.D. Livney, and Y.G. Assaraf Rationally designed nanovehicles to overcome cancer chemoresistance Adv. Drug Deliv. Rev. 65 2013 1716 1730
61. R. Logan, R.S. Funk, E. Axcell, and J.P. Krise Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications Expert Opin. Drug Metabol. Toxicol. 8 2012 943 958
62. S.P. Lutgens, K.B. Cleutjens, M.J. Daemen, and S. Heeneman Cathepsin cysteine proteases in cardiovascular disease FASEB J. 21 2007 3029 3041
63. A.C. MacIntyre, and D.J. Cutler The potential role of lysosomes in tissue distribution of weak bases Biopharm. Drug Dispos. 9 1988 513 526
64. J.A. Martina, Y. Chen, M. Gucek, and R. Puertollano MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB Autophagy 8 2012 903 914
65. D.L. Medina, S. Di Paola, I. Peluso, A. Armani, D. De Stefani, R. Venditti, S. Montefusco, A. Scotto-Rosato, C. Prezioso, A. Forrester, C. Settembre, W. Wang, Q. Gao, H. Xu, M. Sandri, R. Rizzuto, M.A. De Matteis, and A. Ballabio Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB Nat. Cell Biol. 17 2015 288 299
66. D.L. Medina, A. Fraldi, V. Bouche, F. Annunziata, G. Mansueto, C. Spampanato, C. Puri, A. Pignata, J.A. Martina, M. Sardiello, M. Palmieri, R. Polishchuk, R. Puertollano, and A. Ballabio Transcriptional activation of lysosomal exocytosis promotes cellular clearance Dev. Cell 21 2011 421 430
67. A. Molinari, A. Calcabrini, S. Meschini, A. Stringaro, P. Crateri, L. Toccacieli, M. Marra, M. Colone, M. Cianfriglia, and G. Arancia Subcellular detection and localization of the drug transporter P-glycoprotein in cultured tumor cells Curr. Protein Pept. Sci. 3 2002 653 670
68. H. Ohrvik, Y. Nose, L.K. Wood, B.E. Kim, S.C. Gleber, M. Ralle, and D.J. Thiele Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain Proc. Natl. Acad. Sci. U.S.A. 110 2013 E4279 E4288
69. +-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells Biochem. J. 370 2003 185 193
70. M. Palmieri, S. Impey, H. Kang, A. di Ronza, C. Pelz, M. Sardiello, and A. Ballabio Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways Hum. Mol. Genet. 20 2011 3852 3866
71. K. Pena, J. Coblenz, and K. Kiselyov Brief exposure to copper activates lysosomal exocytosis Cell Calcium 57 2015 257 262
72. E.V. Polishchuk, M. Concilli, S. Iacobacci, G. Chesi, N. Pastore, P. Piccolo, S. Paladino, D. Baldantoni, I.S.C. van, J. Chan, C.J. Chang, A. Amoresano, F. Pane, P. Pucci, A. Tarallo, G. Parenti, N. Brunetti-Pierri, C. Settembre, A. Ballabio, and R.S. Polishchuk Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis Dev. Cell 29 2014 686 700
73. A. Rajagopal, and S.M. Simon Subcellular localization and activity of multidrug resistance proteins Mol. Biol. Cell 14 2003 3389 3399
74. R. Safaei, P.L. Adams, M.H. Maktabi, R.A. Mathews, and S.B. Howell The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin J. Inorg. Biochem. 110 2012 8 17
75. R. Safaei, B.J. Larson, T.C. Cheng, M.A. Gibson, S. Otani, W. Naerdemann, and S.B. Howell Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells Mol. Cancer Ther. 4 2005 1595 1604
76. P. Saftig Lysosomes Landes Bioscience/Eurekah.com 2005 Springer Science + Business Media Georgetown, TX; New York, NY
77. P. Saftig, and K. Sandhoff Cancer: killing from the inside Nature 502 2013 312 313
78. M. Sardiello, M. Palmieri, A. di Ronza, D.L. Medina, M. Valenza, V.A. Gennarino, C. Di Malta, F. Donaudy, V. Embrione, R.S. Polishchuk, S. Banfi, G. Parenti, E. Cattaneo, and A. Ballabio A gene network regulating lysosomal biogenesis and function Science 325 2009 473 477
79. M. Schindler, S. Grabski, E. Hoff, and S.M. Simon Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr) Biochemistry 35 1996 2811 2817
80. C. Settembre, A. Fraldi, D.L. Medina, and A. Ballabio Signals from the lysosome: a control centre for cellular clearance and energy metabolism Nat. Rev. Mol. Cell Biol. 14 2013 283 296
81. C. Settembre, R. Zoncu, D.L. Medina, F. Vetrini, S. Erdin, S. Erdin, T. Huynh, M. Ferron, G. Karsenty, M.C. Vellard, V. Facchinetti, D.M. Sabatini, and A. Ballabio A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB EMBO J. 31 2012 1095 1108
82. P.J. Smith, H.R. Sykes, M.E. Fox, and I.J. Furlong Subcellular distribution of the anticancer drug mitoxantrone in human and drug-resistant murine cells analyzed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage Cancer Res. 52 1992 4000 4008
83. I.S. Song, N. Savaraj, Z.H. Siddik, P. Liu, Y. Wei, C.J. Wu, and M.T. Kuo Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells Mol. Cancer Ther. 3 2004 1543 1549
84. +)-ATPase Annu. Rev. Cell Dev. Biol. 13 1997 779 808
85. R. Sundler Lysosomal and cytosolic pH as regulators of exocytosis in mouse macrophages Acta Physiol. Scand. 161 1997 553 556
86. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat. Rev. Drug Discov. 5 2006 219 234
87. F. Tadini-Buoninsegni, G. Bartolommei, M.R. Moncelli, G. Inesi, A. Galliani, M. Sinisi, M. Losacco, G. Natile, and F. Arnesano Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B Angew. Chem. Int. Ed. Engl. 53 2014 1297 1301
88. P.V. van den Berghe, D.E. Folmer, H.E. Malingre, E. van Beurden, A.E. Klomp, B. van de Sluis, M. Merkx, R. Berger, and L.W. Klomp Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake Biochem. J. 407 2007 49 59
89. X. Xu, L. Duan, B. Zhou, R. Ma, H. Zhou, and Z. Liu Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients Clin. Exp. Pharmacol. Physiol. 39 2012 786 792
90. T. Yamagishi, S. Sahni, D.M. Sharp, A. Arvind, P.J. Jansson, and D.R. Richardson P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration J. Biol. Chem. 288 2013 31761 31771
91. R.E. Yanes, D. Tarn, A.A. Hwang, D.P. Ferris, S.P. Sherman, C.R. Thomas, J. Lu, A.D. Pyle, J.I. Zink, and F. Tamanoi Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition Small 9 2013 697 704
92. B. Zhitomirsky, and Y.G. Assaraf Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance Oncotarget 6 2015 1143 1156
93. B. Zhitomirsky, and Y.G. Assaraf The role of cytoplasmic-to-lysosomal pH gradient in hydrophobic weak base drug sequestration in lysosomes Cancer Cell Microenviron. 2 2015 e807
94. D. Zong, P. Haag, I. Yakymovych, R. Lewensohn, and K. Viktorsson Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of gammaH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation Cell Death Dis. 2 2011 e181
95. D. Zong, K. Zielinska-Chomej, T. Juntti, B. Mork, R. Lewensohn, P. Haag, and K. Viktorsson Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer Cell Death Dis. 5 2014 e1111